{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:49:33Z","timestamp":1784695773608,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbrc.2024.151085","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T23:50:03Z","timestamp":1732837803000},"page":"151085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Lipid mediator palmitoylethanolamide (PEA) inhibits pathogenic T cell differentiation in vitro and in vivo"],"prefix":"10.1016","volume":"743","author":[{"given":"Yasuhiro","family":"Soga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naganori","family":"Kamiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyakorn","family":"Chalalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Sachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"Ozaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yomei","family":"Kagoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supanuch","family":"Ekronarongchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6821-2785","authenticated-orcid":false,"given":"Masahiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9069-5736","authenticated-orcid":false,"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.151085_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1538\/expanim.60.7","article-title":"Lipid mediators in life science","volume":"60","author":"Murakami","year":"2011","journal-title":"Exp. Anim."},{"key":"10.1016\/j.bbrc.2024.151085_bib2","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","article-title":"Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity","volume":"81","author":"Yoon","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2024.151085_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","article-title":"Inflammation 2010: new adventures of an old flame","volume":"140","author":"Medzhitov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.151085_bib4","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gutjnl-2013-305005","article-title":"Palmitoylethanolamide improves colon inflammation through an enteric glia\/toll like receptor 4-dependent PPAR-\u03b1 activation","volume":"63","author":"Esposito","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2024.151085_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.12907","article-title":"Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent","volume":"172","author":"Borrelli","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151085_bib6","article-title":"Palmitoylethanolamide: a natural body-own anti-inflammatory agent, effective and safe against influenza and common cold","volume":"2013","author":"Hesselink","year":"2013","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.bbrc.2024.151085_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/gtc.12944","article-title":"Comprehensive lipidomics of lupus-prone mice using LC-MS\/MS identifies the reduction of palmitoylethanolamide that suppresses TLR9-mediated inflammation","volume":"27","author":"Ozaki","year":"2022","journal-title":"Gene Cell."},{"key":"10.1016\/j.bbrc.2024.151085_bib8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.1999","article-title":"Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury","volume":"15","author":"Shichita","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2024.151085_bib9","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.4049\/jimmunol.0900547","article-title":"SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis","volume":"183","author":"Nakaya","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2024.151085_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/intimm\/dxad055","article-title":"TRAF6 signaling in T cells is crucial for the pathogenicity of experimental autoimmune encephalomyelitis","volume":"36","author":"Kamiyama","year":"2024","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbrc.2024.151085_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2012.06.009","article-title":"A cluster of interferon-\u03b3-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii","volume":"37","author":"Yamamoto","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2024.151085_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.151085_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.immuni.2020.12.010","article-title":"The TGF-\u03b2 superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation","volume":"54","author":"Wu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2024.151085_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.151085_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2035117","article-title":"Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - advances and challenges","volume":"18","author":"Goswami","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.bbrc.2024.151085_bib16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/35105024","article-title":"T-cell regulation by CD28 and CTLA-4","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2024.151085_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2010.22","article-title":"The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease","volume":"7","author":"Leung","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbrc.2024.151085_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","article-title":"Role of Th1 and Th17 cells in organ-specific autoimmunity","volume":"31","author":"Dardalhon","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbrc.2024.151085_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1183\/09031936.05.00006005","article-title":"T-helper cell type-2 regulation in allergic disease","volume":"26","author":"Georas","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2024.151085_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/biom10030487","article-title":"TGF-\u0392 signaling","volume":"10","author":"Tzavlaki","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2024.151085_bib21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.181.5.1755","article-title":"Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4","volume":"181","author":"Jacobson","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2024.151085_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/380627a0","article-title":"Essential role of Stat6 in IL-4 signalling","volume":"380","author":"Takeda","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.151085_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.151085_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.immuni.2020.07.012","article-title":"The conserved non-coding sequences CNS6 and CNS9 control cytokine-induced Rorc transcription during T helper 17 cell differentiation","volume":"53","author":"Chang","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2024.151085_bib25","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.151085_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/oby.2008.591","article-title":"Anti-inflammatory effect of palmitoylethanolamide on human adipocytes","volume":"17","author":"Hoareau","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.bbrc.2024.151085_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151085_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156198","article-title":"Palmitoylethanolamide modulates inflammation-associated Vascular Endothelial Growth Factor (VEGF) signaling via the Akt\/mTOR pathway in a selective peroxisome proliferator-activated receptor alpha (PPAR-\u03b1)-dependent manner","volume":"11","author":"Sarnelli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.151085_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4049\/jimmunol.171.1.196","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation","volume":"171","author":"Jones","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2024.151085_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s42003-023-05104-6","article-title":"Ppar\u03b1 knockout in mice increases the Th17 development by facilitating the IKK\u03b1\/ROR\u03b3t and IKK\u03b1\/Foxp3 complexes","volume":"6","author":"Wei","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2024.151085_bib31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fphar.2017.00857","article-title":"Palmitoylethanolamide supplementation during sensitization prevents airway allergic symptoms in the mouse","volume":"8","author":"Roviezzo","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151085_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuroscience.2015.01.030","article-title":"Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL\/6 mice","volume":"290","author":"Rahimi","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2024.151085_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40257-020-00578-0","article-title":"Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review","volume":"22","author":"Yang","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.bbrc.2024.151085_bib34","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/ecco-jcc\/jjac034","article-title":"Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention","volume":"16","author":"Sewell","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bbrc.2024.151085_bib35","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Floc\u2019h","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.bbrc.2024.151085_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3389\/fphar.2019.00821","article-title":"Palmitoylethanolamide (PEA) as a potential therapeutic agent in Alzheimer's disease","volume":"10","author":"Beggiato","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151085_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871527311312010007","article-title":"Measurement of palmitoylethanolamide and other N-acylethanolamines during physiological and pathological conditions","volume":"12","author":"Balvers","year":"2013","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.bbrc.2024.151085_bib38","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/bph.13084","article-title":"The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels","volume":"173","author":"Petrosino","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151085_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fphar.2018.00249","article-title":"Oral ultramicronized palmitoylethanolamide: plasma and tissue levels and spinal anti-hyperalgesic effect","volume":"9","author":"Petrosino","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24016218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24016218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:10:07Z","timestamp":1735067407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24016218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"alternative-id":["S0006291X24016218"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151085","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid mediator palmitoylethanolamide (PEA) inhibits pathogenic T cell differentiation in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151085"}}